CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Market share analysis, 2019
3.4.Porter's five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.High prevalence of hematologic diseases
3.5.1.2.Rise in accidents
3.5.1.3.Growth in geriatric population
3.5.2.Restraints
3.5.2.1.Wastage of donated blood
3.5.2.2.Stringent rules and regulations
3.5.3.Opportunity
3.5.3.1.Blood transfusion in emerging nations
3.6.Pricing Analysis
CHAPTER 4:BLOOD BANK MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Whole blood
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Red blood Cell
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Platelet
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Plasma
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.6.White blood cell
4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country
CHAPTER 5:BLOOD BANK MARKET, BY FUNCTION
5.1.Overview
5.1.1.Market size and forecast
5.2.Collection
5.2.1.Market size and forecast
5.2.2.Market analysis, by country
5.3.Processing
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Testing
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Storage
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Transportation
5.6.1.Market size and forecast
5.6.2.Market analysis, by country
CHAPTER 6:BLOOD BANK MARKET, BY BANK TYPE
6.1.Overview
6.1.1.Market size and forecast
6.2.Private
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Public
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
CHAPTER 7:BLOOD BANK MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospital
7.2.1.Market size and forecast
7.2.2.Market analysis, by country
7.3.Ambulatory surgery centers
7.3.1.Market size and forecast
7.3.2.Market analysis, by country
7.4.Pharmaceutical companies
7.4.1.Market size and forecast
7.4.2.Market analysis, by country
7.5.Clinics & Nursing homes
7.5.1.Market size and forecast
7.5.2.Market analysis, by country
7.6.Others
7.6.1.Market size and forecast
7.6.2.Market analysis, by country
CHAPTER 8:BLOOD BANK MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.North America blood bank market, by country
8.2.2.1.U.S. blood bank market, by product type
8.2.2.2.U.S. blood bank market, by function
8.2.2.3.U.S. blood bank market by bank type
8.2.2.4.U.S. blood bank market, by end user
8.2.2.5.Canada blood bank market, by product type
8.2.2.6.Canada blood bank market, by function
8.2.2.7.Canada blood bank market by bank type
8.2.2.8.Canada blood bank market, by end user
8.2.2.9.Mexico blood bank market, by product type
8.2.2.10.Mexico blood bank market, by function
8.2.2.11.Mexico blood bank market by bank type
8.2.2.12.Mexico blood bank market, by end user
8.2.3.North America blood bank market, by product type
8.2.4.North America blood bank market, by function
8.2.5.North America blood bank market, by bank type
8.2.6.North America blood bank market, by end user
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Europe blood bank market, by country
8.3.2.1.Germany blood bank market, by product type
8.3.2.2.Germany blood bank market, by function
8.3.2.3.Germany blood bank market by bank type
8.3.2.4.Germany blood bank market, by end user
8.3.2.5.France blood bank market, by product type
8.3.2.6.France blood bank market, by function
8.3.2.7.France blood bank market by bank type
8.3.2.8.France blood bank market, by end user
8.3.2.9.UK blood bank market, by product type
8.3.2.10.UK blood bank market, by function
8.3.2.11.UK blood bank market by bank type
8.3.2.12.UK blood bank market, by end user
8.3.2.13.Rest of Europe blood bank market, by product type
8.3.2.14.Rest of Europe blood bank market, by function
8.3.2.15.Rest of Europe blood bank market by bank type
8.3.2.16.Rest of Europe blood bank market, by end user
8.3.3.Europe blood bank market, by product type
8.3.4.Europe blood bank market, by function
8.3.5.Europe blood bank market, by bank type
8.3.6.Europe blood bank market, by end user
8.4.Asia-pacific
8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific blood bank market, by country
8.4.2.1.Australia blood bank market, by product type
8.4.2.2.Australia blood bank market, by function
8.4.2.3.Australia blood bank market by bank type
8.4.2.4.Australia blood bank market, by end user
8.4.2.5.Japan blood bank market, by product type
8.4.2.6.Japan blood bank market, by function
8.4.2.7.Japan blood bank market by bank type
8.4.2.8.Japan blood bank market, by end user
8.4.2.9.India blood bank market, by product type
8.4.2.10.India blood bank market, by function
8.4.2.11.India blood bank market by bank type
8.4.2.12.India blood bank market, by end user
8.4.2.13.China blood bank market, by product type
8.4.2.14.China blood bank market, by function
8.4.2.15.China blood bank market by bank type
8.4.2.16.China blood bank market, by end user
8.4.2.17.Rest of Asia-Pacific blood bank market, by product type
8.4.2.18.Rest of Asia-Pacific blood bank market, by function
8.4.2.19.Rest of Asia-Pacific blood bank market by bank type
8.4.2.20.Rest of Asia-Pacific blood bank market, by end user
8.4.3.Asia-Pacific blood bank market, by product type
8.4.4.Asia-Pacific blood bank market, by function
8.4.5.Asia-Pacific blood bank market, by bank type
8.4.6.Asia-Pacific blood bank market, by end user
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.LAMEA blood bank market, by country
8.5.2.1.Brazil blood bank market, by product type
8.5.2.2.Brazil blood bank market, by function
8.5.2.3.Brazil blood bank market by bank type
8.5.2.4.Brazil blood bank market, by end user
8.5.2.5.Saudi Arabia blood bank market, by product type
8.5.2.6.Saudi Arabia blood bank market, by function
8.5.2.7.Saudi Arabia blood bank market by bank type
8.5.2.8.Saudi Arabia blood bank market, by end user
8.5.2.9.South Africa blood bank market, by product type
8.5.2.10.South Africa blood bank market, by function
8.5.2.11.South Africa blood bank market by bank type
8.5.2.12.South Africa blood bank market, by end user
8.5.2.13.Rest of LAMEA blood bank market, by product type
8.5.2.14.Rest of LAMEA blood bank market, by function
8.5.2.15.Rest of LAMEA blood bank market by bank type
8.5.2.16.Rest of LAMEA blood bank market, by end user
8.5.3.LAMEA blood bank market, by product type
8.5.4.LAMEA blood bank market, by function
8.5.5.LAMEA blood bank market, by bank type
8.5.6.LAMEA blood bank market, by end user
CHAPTER 9:COMPANY PROFILES
9.1.AMERICAN ASSOCIATION OF BLOOD BANKS
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Business performance
9.2.AMERICA'S BLOOD CENTERS
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Business performance
9.3.AUSTRALIAN RED CROSS SOCIETY
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Business performance
9.4.BLOOD BANK OF ALASKA
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.5.CANADIAN BLOOD SERVICES
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Business performance
9.6.JAPANESE RED CROSS SOCIETY
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.7.NEW YORK BLOOD CENTRE
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.8.SANQUIN BLOOD SUPPLY FOUNDATION
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Business performance
9.9.THE AMERICAN RED CROSS
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Business performance
9.10.VITALANT
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Business performance